Showing results (511-520 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|July 25, 2012
Referral-free health care and delay in diagnosis for lung cancer patientsVivian Chia-Rong Hsieh, Trong-Neng Wu, Shu-Hui Liu, et al.
Japanese Journal of Clinical Oncology|August 15, 1998
Phase II study of 5-fluorouracil, pirarubicin and low-dose consecutive administration of cisplatin for advanced and recurrent gastric cancerS Kikuyama, T Inada, M Miyakita, et al.
Japanese Journal of Clinical Oncology|August 15, 1998
Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancerT J Chiou, S L Tung, R K Hsieh, et al.
Japanese Journal of Clinical Oncology|August 15, 1998
Nested consent design for clinical trialsN Hamajima, H Yuasa, M Nakamura, et al.
Japanese Journal of Clinical Oncology|July 17, 2012
A review of update clinical results of carbon ion radiotherapyHirohiko Tsujii, Tadashi Kamada
Japanese Journal of Clinical Oncology|September 7, 2012
Watchful waiting versus intravesical BCG therapy for high-grade pT1 bladder cancer with pT0 histology after second transurethral resection: Japan Clinical Oncology Group Study JCOG1019Futoshi Kunieda, Hiroshi Kitamura, Masashi Niwakawa, et al.
Japanese Journal of Clinical Oncology|September 29, 2012
Recent development of gastric cancer preventionMototsugu Kato, Masahiro Asaka
Japanese Journal of Clinical Oncology|October 2, 2012
Recent developments in the management of cancer pain in Japan: education, clinical guidelines and basic researchTakashi Yamaguchi, Minoru Narita, Tatsuya Morita, et al.
Japanese Journal of Clinical Oncology|September 18, 2012
Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximabTsutomu Kobayashi, Yasuhiko Tsutsumi, Natsumi Sakamoto, et al.
Japanese Journal of Clinical Oncology|August 4, 2012
Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trialTetsuhide Ito, Takuji Okusaka, Masafumi Ikeda, et al.
Pageof 534